TNFRSF4 and neoplasm: Enhanced OX40 signaling induced by OX40 agonist antibodies has been observed to augment the T cell-mediated anti-tumor immunity and support enhanced T cell infiltration into tumors, which further results in tumor regression and prolonged survival.